Mercury Labs

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947G01011
  • NSEID:
  • BSEID: 538964
INR
721.00
0.00 (0.00%)
BSENSE

Apr 02

BSE+NSE Vol: 2

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -0.61% vs 0.30% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -22.30% vs 5.36% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 43.00% vs 5.83% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -44.38% vs 1.35% in Mar 2024

Compare Profit and Loss Results of Mercury Labs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
75.00
43.00
32.00
74.42%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
75.00
43.00
32.00
74.42%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
3.00
-3.00
-100.00%
Raw Materials Consumed
29.00
2.00
27.00
1,350.00%
Power & Fuel Cost
1.00
18.00
-17.00
-94.44%
Employee Cost
16.00
16.00
0.00
0.00%
Operating Expenses
0.00
12.00
-12.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
0.00
5.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
0.00
5.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
68.00
58.00
10.00
17.24%
Operating Profit (PBDIT) excl Other Income
7.00
-15.00
22.00
146.67%
Other Income
1.00
0.00
1.00
0%
Operating Profit (PBDIT)
8.00
-14.00
22.00
157.14%
Interest
0.00
5.00
-5.00
-100.00%
Profit before Depriciation and Tax
7.00
-20.00
27.00
135.00%
Depreciation
2.00
6.00
-4.00
-66.67%
Profit Before Taxation & Exceptional Items
4.00
-26.00
30.00
115.38%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
-26.00
30.00
115.38%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
3.00
-26.00
29.00
111.54%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
5.00
-270.00
275.00
101.85%
Profit Available for appropriations
9.00
-297.00
306.00
103.03%
Appropriations
9.00
-297.00
306.00
103.03%
Equity Dividend (%)
35%
0%
35.00
Earnings Per Share
26.21
-12.49
38.70
309.85%
Profit And Loss - Net Sales
Net Sales 75.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -0.61% vs 0.30% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.02 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -22.30% vs 5.36% in Mar 2024

Profit And Loss - Interest
Interest 0.55 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 43.00% vs 5.83% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 3.14 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -44.38% vs 1.35% in Mar 2024